Parkinson’s disease - search results

Parkinson’s rating scales are a vital assessment tool, but have their limitations. Jennifer Stratten explains how and why the EPDA developed a new one

Today, stakeholders from across the globe will unite to raise awareness of Parkinson’s during a dedicated campaign

Writing on behalf of the Chartered Society of Physiotherapy, Dr. Bhanu Ramaswamy highlights how physiotherapy can help manage the symptoms of Parkinson’s

Dr Mehis Pilv, CEO and business development lead at Genecode, discusses the strides being made in Parkinson's disease research Parkinson's disease is a slow but progressive neurodegenerative disorder. About 1% of people aged above 50 are affected worldwide. In Europe alone 1.2 million people suffer from Parkinson's disease, 127,000 of whom...

UCB's Duncan McHale outlines why reclassification might be a good idea to boost drug development for neurodegenerative diseases like Alzheimer's and Parkinson's Neurodegenerative diseases are a growing global challenge, as medical advances ensure more individuals live longer. By 2020 there will be more than 40 million people in the world...

My PD Journey – a project from the European Parkinson’s Disease Association (EPDA) looks at how challenges need to be tackled better at a European level in order to drive changes and improve diagnosis On the occasion of Parkinson’s Awareness Month in April 2016, President of the European Parkinson’s Disease...

Frédéric Destrebecq, Executive Director, and Vinciane Quoidbach, Public Health and Policy Project Manager at the European Brain Council, explain the socio-economic impact of interventions and the importance of early diagnosis with regard to brain disorders… Depression, stroke, dementia, alcohol dependence, schizophrenia or anxiety will affect at least one in three...

Neurodegenerative diseases are a growing global challenge as medical advances ensures more individuals live longer. By 2020 there will be more than 40 million individuals in the world with Alzheimer’s disease and by 2040, without the development of truly disease modifying drugs this will be more than 80 million.

Professor Duncan McHale, Head Global Exploratory Development, UCB discusses reclassifying neurodegenerative diseases to enable drug development and to help patients... Neurodegenerative diseases are a growing global challenge as medical advances ensures more individuals live longer.  By 2020 there will be more than 40 million individuals in the world with Alzheimer’s disease and...

Professor Duncan McHale discusses neurodegenerative disease research... Neurodegenerative diseases are a growing global challenge as medical advances ensures more individuals live longer.  By 2020 there will be > 40 million individuals in the world with Alzheimer’s disease and by 2040 without the development of truly disease modifying drugs this will...

Background of Alzheimer’s disease Alzheimer’s disease (AD) is one of the most devastating neurodegenerative disorders affecting more than 25 million people worldwide which is the fifth leading cause of death for those aged 65 years and above. The disease typically starts with a difficulty to remember new information and as...

Claire Bale, Communications Manager for Parkinson’s UK, highlights the latest thinking in stem cell research for the potential treatment of Parkinson’s. Stem cells can develop into almost any cell in the body. They are the original cells from which we are made, and are responsible for repairing our tissues and...

In an interview with Clair Mace, examined what the Personal KinetiGraph can really do for patients dealing with Parkinson’s disease.

Monitoring brain health, particularly cognition, in older adults is increasingly recognised as a significant priority for research, healthcare and broader public health. Find out here about the development and validation of the FLAME System, a computerised cognitive assessment for remote brain health monitoring.

Satyajit Hari Kulkarni and Christopher H. Contag from the Institute for Quantitative Health Science and Engineering focus on engineered endosymbionts, which they argue is a paradigm shift in anticancer bacteriotherapy toward killing tumors from the inside out.

Meeting the rapid developments in biotechnology by fostering transdisciplinarity, including digitalisation and big data, to create convergence for innovation in a virtual centre.

Dr Deborah Lee from Dr Fox Online Pharmacy discusses men’s mental health, including common barriers to seeking help and the measures needed to improve overall awareness and support.

Regular exercise is a critical step in maintaining healthy physiology and ensuring healthy aging. However, there are many diseases and conditions that make exercise inaccessible or reduce its efficacy. The Wessells lab studies exercise and the pathways it works through to identify key molecules required for a proper exercise response.

The position here is that public policies should, ultimately speaking, be for the promotion of social welfare. What is social welfare? This is the welfare of people in the relevant society (discussing the issue of animal welfare later).

CorTec’s Brain Interchange™ system offers closed-loop neuromodulation, revolutionizing brain therapy by precisely adapting treatment based on individual needs.